Mpro of Severe acute respiratory Coronavirus 2 is essential for viral replication by processing the polyproteins 1ab at 11 cleavage sites. Inhibiting the activity of this enzyme would block viral replication, therefore, it becomes a promising target for the development of anti-coronaviral therapeutic agents.